ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

Plastomics, Inc. enhances its research and development capabilities with key new hire

Industry veteran joins as Vice-President of Research and Development

SAINT LOUIS, MO, USA, June 28, 2021 /EINPresswire.com/ -- Plastomics, Inc., the biotechnology company developing a transformative platform for transgenic trait introduction via the chloroplast, announces the hire of distinguished industry veteran, Dr. Charles (Chuck) L. Armstrong, to the position of Vice President, Research and Development (R&D). Dr. Armstrong will join Dr. Jeffrey Staub, Chief Technology Officer (CTO) and Plastomics founder, in leading the overall R&D pipeline.

Dr. Armstrong joins Plastomics after an illustrious 33-year career at Monsanto Company and Bayer Crop Sciences. Among Chuck’s many career highlights are the publication of several early seminal works on corn transformation, the development of multiple transformation competent lines of maize still used routinely in both academia and industry, as well as being part of the team that generated the first fertile transgenic corn plants in 1990. Chuck has been honored as the recipient of numerous prestigious awards including the Queeny Award for his role in the development of RoundUp Ready® 2 and Yieldgard® Corn products, the Monsanto Science and Technology Career Award and the James B. Eads Award from the St. Louis Academy of Science. Chuck has been a Senior Science Fellow since 2002 and Associate Editor of In Vitro -Plant since 1992.

Dr. Staub commented, “I had the good fortune to work alongside Chuck for many years at Monsanto and more recently to benefit from his counsel as a member of the Plastomics Scientific Advisory Board. I’m thrilled to join forces with Chuck again to shepherd corn chloroplast transformation to a commercial reality.” Dr. Robert Fraley, Monsanto CTO over much of Chuck’s career noted, “Chuck brings a wealth of experience and expertise in the development of valuable new technologies to enhance corn productivity. He is a fantastic addition to the Plastomics team.”

“With the advancement of Plastomics’ soybean chloroplast pipeline to proof-of-concept for potential commercial product concepts, and the corn chloroplast transformation pipeline following closely behind, it has been important for us to add technical and strategic strength to augment the already strong core team”, stated Dr. Martha Schlicher, Plastomics CEO.

Plastomics continues to advance its transformative platforms for both soybeans and corn from laboratory to greenhouse testing. The chloroplast transformation trait introduction system has been demonstrated at greenhouse scale through two generations in soybean and the corn platform is advancing using multiple proprietary approaches. Chloroplast transformation provides many benefits not possible with traits introduced via the nucleus at a time when the industry is desperate for new solutions, including technology to overcome broad spread insect resistance to current commercial traits. These benefits include the introduction of traits with new modes of action and traits that have the potential to enhance yield – further reducing the environmental footprint of crop production.

About Plastomics, Inc.
Plastomics, Inc. is a novel early-stage biotechnology company developing a new and better way of introducing biotech traits into row crops like corn and soybeans. The St. Louis based company, resides in the 39 North innovation district with laboratories and corporate offices at Helix Incubator and greenhouse operations at the Donald Danforth Plant Science Center. Learn more at www.Plastomics.com

Martha Schlicher
Plastomics, Inc.
+1 314-703-7198
martha@plastomics.com

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.